Skip to main content
. 2018 Aug 23;7(3):119–123. doi: 10.4103/GMIT.GMIT_35_18
Uterine volume Before treatment (cm3) After 16 weeks of treatment (cm3) P
GnRHa (n=26) 307.4±230.1 177.9±142.1 <0.001
LEP (n=15) 226.7±116.6 230.5±128.6 0.85
DNG (n=11) 232.6±117.8 262.1±136.8 0.36

Value: Mean±SD. GnRHa: Gonadotropin-releasing hormone agonist, LEP: Low-dose estrogen-progestin combinations, DNG: Dienogest, SD: Standard deviation

HHS Vulnerability Disclosure